Zobrazeno 1 - 10
of 66
pro vyhledávání: '"M. G. J. Tilanus"'
Publikováno v:
HLA. 90(2)
HLA-A*02:683 is most similar to 4 different HLA-A*02 subtypes with a single nucleotide difference.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::83eefb97d8ffd1eaca9f74871509f2d9
https://pubmed.ncbi.nlm.nih.gov/28556601
https://pubmed.ncbi.nlm.nih.gov/28556601
Publikováno v:
HLA. 89(3)
Human leukocyte antigen (HLA)-E is a non-classical HLA class I molecule that plays a role in both the innate and the adaptive immune response through interaction with receptors on natural killer- and T-cells. The HLA-E gene is characterized by limite
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3f9054134789525f7e7c48d4aac733ed
https://pubmed.ncbi.nlm.nih.gov/28127896
https://pubmed.ncbi.nlm.nih.gov/28127896
Publikováno v:
Tissue antigens. 86(5)
Currently 1582 HLA-DRB1 alleles have been identified in the IMGT/HLA database (v3.18). Among those alleles, more than 90% have incomplete allele sequences, which complicates the analysis of the functional relevance of polymorphism beyond exon 2. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a77c7d2eab1206c80b3372dc190871b6
https://pubmed.ncbi.nlm.nih.gov/26396036
https://pubmed.ncbi.nlm.nih.gov/26396036
Publikováno v:
Tissue antigens. 86(1)
The full length sequence of HLA-A*02:455 differs from HLA-A*02:01:01:01 by one amino acid substitution: A245E.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7fe1e00c9d189ad7f15073ef796a857d
https://pubmed.ncbi.nlm.nih.gov/25959797
https://pubmed.ncbi.nlm.nih.gov/25959797
Autor:
Erik H. Rozemuller, Milena Ivanova, A. Michailova, M. G. J. Tilanus, Elissaveta Naumova, N. Tyufekchiev
Publikováno v:
Tissue Antigens. 60:496-504
In the present study we analyzed for the first time HLA class I and class II polymorphisms defined by high-resolution typing methods in the Bulgarian population. Comparisons with other populations of common historical background were performed. Most
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d0b651a4724deeeec817e4008decc4d0
https://doi.org/10.1034/j.1399-0039.2002.600605.x
https://doi.org/10.1034/j.1399-0039.2002.600605.x
Publikováno v:
Tissue antigens. 84(6)
Human leukocyte antigen-E (HLA-E) is a nonclassical HLA class I molecule that canonically binds peptides derived from the leader sequence of classical HLA class I. HLA-E can also bind peptides from stress protein [e.g. heat shock protein 60 (Hsp60)]
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::14da39e69b5b4439c300f889d00abdb7
https://pubmed.ncbi.nlm.nih.gov/25413103
https://pubmed.ncbi.nlm.nih.gov/25413103
Publikováno v:
Tissue antigens. 85(1)
HLA-C*03:219 differs from HLA-C*03:04:01:01 by a non-synonymous substitution in the α3 domain (T216I).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1135c56a9675210cc90dad2a372ec61f
https://pubmed.ncbi.nlm.nih.gov/25515183
https://pubmed.ncbi.nlm.nih.gov/25515183
Autor:
N, Lauterbach, L, Wieten, H E, Popeijus, J, Vanderlocht, P M H, van Zon, C E M, Voorter, M G J, Tilanus
Publikováno v:
Tissue antigens. 85(4)
Human Leukocyte Antigen (HLA)-E is a low-polymorphic non-classical HLA class I molecule which plays a crucial role in immune surveillance by presentation of peptides to T and natural killer (NK) cells. HLA-E polymorphism is related to HLA-E surface e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ba5951431aed246a57e850a674c1349a
https://pubmed.ncbi.nlm.nih.gov/25735891
https://pubmed.ncbi.nlm.nih.gov/25735891
Publikováno v:
Molecular Pathology. 54:192-196
Background—Connective tissue growth factor (CCN2; CTGF) is a newly identified growth factor, which is involved in the regulation of wound repair and fibrosis. Because there is variation among individuals with respect to tissue response to injury, g
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4666bf3735602af27343023bcf2c72f
https://doi.org/10.1136/mp.54.3.192
https://doi.org/10.1136/mp.54.3.192
Autor:
Federico Garrido, M. G. J. Tilanus, Miguel A. López-Nevot, Antonia Collado, A. van der Zwan, Manita Feenstra, L.M. Ramal
Publikováno v:
Tissue Antigens. 55:443-448
Short tandem repeat (STR) markers are currently used to define loss of heterozygosity (LOH) of genes and chromosomes in tumors. Chromosome 6 and chromosome 15 STR markers are applied to define loss of HLA and related genes (e.g. TAP and beta(2)m) The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6ecaea25e34f16ad23d11cfb44923f54
https://doi.org/10.1034/j.1399-0039.2000.550507.x
https://doi.org/10.1034/j.1399-0039.2000.550507.x